TruaceTracing the truth around AITuesday, September 15, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,419 results
Show filters and sorting

AI gains · 788

68
GainHealth· Stable· Evidence: Moderate (1 source)

Integrated machine learning models using CT radiomics and clinical predictors achieved accurate preoperative prediction of synchronous liver metastasis in pancreatic ductal adenocarcinoma in validation, intended to assist decisions on surveillance versus biopsy or neoadjuvant therapy for indeterminate subcentimeter CT-

In a retrospective study of 340 pancreatic ductal adenocarcinoma patients, investigators developed machine learning models combining CT radiomics and clinical predictors to predict synchronous liver metastasis preoperatively. In an independent validation cohort of 102 patients, the best linear model (LDA) reached AUC 0.828 and the nonlinear model (MLP) reached AUC 0.822, both showing good calibration with Hosmer-Lemeshow P values of 0.551 and 0.682.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 27, 2026 · TRV-2026-0907

68
GainHealth· Stable· Evidence: Moderate (1 source)

Systematic review and meta-analysis of 15 brain tumor studies found deep learning synthesis of postcontrast T1-weighted MRI from precontrast sequences alone is technically feasible with high whole-image similarity.

Researchers systematically reviewed 41 studies through January 2025 that used deep learning to generate synthetic postcontrast T1-weighted MRI from precontrast images alone, aiming to reduce gadolinium use. Most work was in neuroimaging, using GANs and CNNs, and a targeted meta-analysis of 15 brain tumor studies reported high whole-image similarity metrics.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 27, 2026 · TRV-2026-0904

68
GainScience· Stable· Evidence: Moderate (1 source)

Adaptive boosting support vector regression trained on GC parameters predicts retention times with high accuracy, enabling optimization of capillary gas chromatography to separate coeluted C1-C12 hydrocarbon isomers.

Researchers built a machine learning pipeline to predict retention times in capillary gas chromatography, training six algorithms on 608 data points covering 73 instrument settings and 61 C1-C12 hydrocarbons from RESTEK chromatograms and literature. The adaptive boosting support vector regression model achieved R2 scores of 0.992-0.993 on validation and testing sets.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 27, 2026 · TRV-2026-0903

68
GainHealth· Stable· Evidence: Moderate (1 source)

AI-assisted ultrasound of the rectus femoris quantified intramuscular fat percentage (FATi), which was independently associated with diabetic nephropathy and adverse metabolic profiles in patients with diabetes.

In a cross-sectional study of 120 diabetes outpatients at a tertiary Endocrinology and Nutrition Department, researchers used the PIIXMED AI-system to analyze rectus femoris ultrasound images and quantify intramuscular fat percentage (FATi). By publication date 2026-08-24, they reported that higher FATi was associated with adverse metabolic profiles and microvascular complications.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 26, 2026 · TRV-2026-0900

AI problems · 631

68
ProblemLifestyle· Stable· Evidence: Moderate (1 source)

Women reported higher AI anxiety and lower positive attitudes, use, and perceived knowledge of AI, indicating gender-related inequalities in accessing and using AI systems

A May 2025 peer-reviewed study surveyed 335 adults about AI anxiety, attitudes, use, and perceived knowledge. It found women reported higher anxiety and lower positive attitudes, use, and perceived knowledge than men, and that higher anxiety correlated with less positive attitudes overall.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 24, 2026 · TRV-2026-0524

68
ProblemCrime· Stable· Evidence: Moderate (1 source)

Fraud-detection models trained for specific scam types often fail to generalize to new fraud types and lose effectiveness when trained on outdated data, with inconsistent performance reporting.

On June 13 2025, Crime Science published a systematic literature review of AI and NLP for online fraud detection. The authors screened 2457 records and analyzed 223 studies, mapping data sources, algorithms, and evaluation metrics across 16 fraud types and summarizing best-performing methods for detecting scams in text.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 24, 2026 · TRV-2026-0521

68
ProblemPolicy· Stable· Evidence: Moderate (1 source)

Current GDPR and AI Act definitions of automated decision-making fail to capture real-life applications where automated systems assist rather than replace human decision-makers in migration and asylum.

Published March 2024, this peer-reviewed article analyzes automated systems used in public decision-making for migration, asylum and mobility. It finds that GDPR and AI Act definitions centered on fully automated decisions miss common practices where systems assist human decision-makers, and it proposes a taxonomy to support fundamental rights analysis.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 23, 2026 · TRV-2026-0519

68
ProblemScience· Stable· Evidence: Moderate (1 source)

Application of AI to implementation faces persistent risks of insufficient or biased data, equity and access barriers, and concerns around data security, trust and ethics requiring oversight.

The paper reviews persistent bottlenecks in moving evidence-based interventions into routine care and describes how data science and AI methods can help extract and synthesize implementation materials, analyze context, and support stakeholder engagement and adaptation, illustrated with a live precision oncology project and the ImpleMATE platform.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%90

Updated Jul 23, 2026 · TRV-2026-0517

Recomputed live from the record · Sep 15, 2026, 8:48 PM